
	Chemical structure search How to Search	Import MOLfile format is only available (V3000 format is not available) Exact match Substructure search Superstructure search Substructure or superstructure search Similarity search

Details
Related links
Search

Co-authoring Researcher

Co-inventing Researcher

Researcher similar to the Researcher

Article similar to the Researcher

Patent similar to the Researcher

Research Project similar to the Researcher

Article(J-GLOBAL estimation)

Patent(J-GLOBAL estimation)

Rchr

J-GLOBAL ID：201901020005834933 Update date: Dec. 05, 2024

Kagabu Masahiro

カガブマサヒロ | Kagabu Masahiro

Clips

Affiliation and department：

Research field (1)： Obstetrics and gynecology

Research keywords (2)： Cancer Immunology , Gynecologic oncology

Research theme for competitive and other funds (5)：

2022 - 2025 子宮癌肉腫に対する免疫逃避改善を誘導するウイルス療法の開発
2021 - 2024 Development of tumor-host integrative therapies to overcome the refractory nature of uterine serous carcinoma
2019 - 2022 卵巣明細胞癌に対するNEFHを標的とした新規治療法の開発
2016 - 2019 The KANK1 pathway may be a novel therapeutic target for ovarian clear cell carcinoma
2016 - 2019 Development of new viral therapy for improvement of immune escape mechanism in ovarian cancer

Papers (59)：

Yohei Chiba, Masahiro Kagabu, Mitsumasa Osakabe, Rikako Ito, Sho Sato, Eriko Takatori, Yoshitaka Kaido, Takayuki Nagasawa, Tadahiro Shoji, Naoki Yanagawa, et al. A single-institution retrospective exploratory analysis on the effectiveness and safety of lenvatinib plus pembrolizumab for advanced endometrial cancer: insights from ProMisE molecular classification system. Japanese journal of clinical oncology. 2024. 54. 4. 424-433
Yohei Chiba, Masahiro Kagabu, Mitsumasa Osakabe, Satoru Nihei, Sho Sato, Eriko Takatori, Yoshitaka Kaido, Takayuki Nagasawa, Tadahiro Shoji, Naoki Yanagawa, et al. Relative dose intensity of lenvatinib for uterine cancer does not affect the efficacy of combination therapy. Proceedings of the Biennial Meeting of Asian Society of Gynecologic Oncology. 2024. 0261-0261
Takayuki Nagasawa, Tadahiro Shoji, Eriko Takatori, Yoshitaka Kaido, Masahiro Kagabu, Dai Shimizu, Tatsuhiko Shigeto, Tsukasa Baba, Toru Sugiyama, Yoshihito Yokoyama. A Phase II Study of S-1 plus Oxaliplatin for Patients with Recurrent Non-Squamous Cell Carcinoma of the Uterine Cervix (Tohoku Gynecologic Cancer Unit: TGCU206 Study). Cancers. 2023. 15. 21. 5201-5201
Tsukasa Baba, Masafumi Koshiyama, Masahiro Kagabu, Yoshiki Mikami, Sachiko Minamiguchi, Suzuko Moritani, Mitsuya Ishikawa, Aikou Okamoto, Yasuhisa Terao, Toru Nakanishi, et al. Ovarian serous borderline tumors with recurrent or extraovarian lesions: a Japanese, retrospective, multi-institutional, population-based study. International journal of clinical oncology. 2023. 28. 10. 1411-1420
Hidehiko Akashi, Nozomi Yachida, Haruka Ueda, Manako Yamaguchi, Kaoru Yamawaki, Ryo Tamura, Kazuaki Suda, Tatsuya Ishiguro, Sosuke Adachi, Yoshikazu Nagase, et al. SLFN11 is a BRCA independent biomarker for the response to platinum-based chemotherapy in high-grade serous ovarian cancer and clear cell ovarian carcinoma. Molecular cancer therapeutics. 2023

ｍore...

MISC (67)：

三浦理絵, 二神真行, 大石舞香, 利部正裕, 庄子忠宏, 馬場長, 三浦康子, 寺田幸弘, 清水孝規, 徳永英樹, et al. 婦人科腫瘍領域におけるトルーソー症候群の臨床的検討. 日本産科婦人科学会雑誌. 2022. 74. 臨増. S-516
Mitsuya Ishikawa, Ryo Kitagawa, Taro Shibata, Hideki Tokunaga, Takashi Iwata, Shin Nishio, Toshio Takada, Masahiko Mori, Koji Horie, Wataru Kudaka, et al. A randomized phase II/III trial of conventional paclitaxel and carboplatin with/without bevacizumab versus dose-dense paclitaxel and carboplatin with/without bevacizumab, in stage IVB, recurrent, or persistent cervical carcinoma (JCOG1311): Results of the phase II part. JOURNAL OF CLINICAL ONCOLOGY. 2020. 38. 15
佐藤誠也, 尾上洋樹, 黒川絵里加, 深川大輔, 佐藤千絵, 深川安寿子, 苫米地英俊, 池田真妃, 永沢崇幸, 利部正裕, et al. 岩手県におけるロボット支援下子宮体癌手術の導入. 産婦人科手術. 2019. 30. 142-142
佐藤誠也, 尾上洋樹, 杣理華子, 黒川絵里加, 深川大輔, 佐藤千絵, 深川安寿子, 苫米地英俊, 永沢崇幸, 利部正裕, et al. 岩手県における早期子宮体癌に対する鏡視下手術の導入. 日本婦人科腫瘍学会雑誌. 2019. 37. 3. 505-505
苫米地英俊, 庄子忠宏, 深川大輔, 深川安寿子, 永沢崇幸, 佐藤誠也, 利部正裕, 板持広明, 馬場長. 進行卵巣癌・卵管癌・原発性腹膜癌に対するIDS完遂度の意義. 日本婦人科腫瘍学会雑誌. 2019. 37. 3. 532-532

ｍore...

Books (6)：

婦人科がん薬物療法パーフェクトガイド
診断と治療社 2021 ISBN:9784787824806
産婦人科専門医のための必修知識
日本産科婦人科学会事務局 2020 ISBN:9784907890223
エビデンスに基づいた癌化学療法ハンドブック
メディカルレビュー社 2018 ISBN:4896007344
産婦人科手術スタンダード
メジカルビュー社 2017 ISBN:9784758317436
EBMがん化学療法・分子標的治療法
中外医学社 2015 ISBN:9784498022461

ｍore...

Education (2)：

1996 - 2000 Iwate Medical University Graduate School of Medical Science
1990 - 1996 Iwate Medical University School of Medicine

Professional career (1)：

医学博士 (岩手医科大学)

Work history (9)：

2023/04 - 現在 Iwate Medical University
2020/07 - 2023/03 Iwate Medical University School of Medicine
2017/01 - 2020/06 Iwate Medical University
2009/09 - 2016/12 Iwate Medical University
2007/09 - 2009/08 University of Pennsylvania Ovarian Cancer Research Center visiting assistant professor

Show all

Committee career (3)：

2022/01 - 現在日本婦人科ロボット手術学会幹事
2020/09 - 現在日本婦人科腫瘍学会子宮頸がん治療ガイドライン2022年版改訂委員会作成幹事
2019/06 - 現在日本臨床細胞学会利益相反員会

Association Membership(s) (7)：

日本がん免疫学会 , 日本臨床細胞学会 , 日本癌治療学会 , 日本癌学会 , 日本婦人科腫瘍学会 , 日本産婦人科医会 , 日本産科婦人科学会

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page


	Free word	※Add the following synonyms, you can increase the number of hits.




		～